血清T_3,T_4,TSH放射免疫测定(RIA)是临床诊断甲状腺疾病的重要指标,已被广泛应用于临床。但是随着RIA工作的普遍开展,国内外许多学者报导,一些非甲状腺疾病也可出现血清T_3,T_4,TSH的改变,目前血清甲状腺激素RIA在非甲状腺疾病的应用已引起人们的关注。作者为了解肝癌患者血清甲状腺激素水平,对87例原发性肝癌患者进行了血清T_3,T_4,TSH测定,现将结果报道如下。 Serum T_3, T_4, TSH radioimmunoassay (RIA) is an important indicator of clinical diagnosis of thyroid disease, has been widely used in clinical. However, with the widespread RIA work, many scholars at home and abroad have reported that serum T_3, T_4 and TSH changes may also occur in some non-thyroid diseases. At present, the application of serum thyroid hormone RIA in non-thyroid diseases has drawn people’s attention. In order to understand the level of serum thyroid hormone in patients with hepatocellular carcinoma, 87 patients with primary liver cancer serum T_3, T_4, TSH determination, the results reported below.